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doi:10.1016/j.ejvs.2010.01.004Abstract Objectives: To present an 8-year clinical experience in the endovascular treatment
of short-necked and juxtarenal abdominal aortic aneurysm (AAA) with fenestrated stent grafts.
Methods: At our tertiary referral centre, all patients treated with fenestrated and branched
stent grafts have been enrolled in an investigational device protocol database. Patients with
short-necked or juxtarenal AAA managed with fenestrated endovascular aneurysm repair
(F-EVAR) between November 2001 and April 2009 were retrospectively reviewed. Patients
treated at other hospitals under the supervision of the main author were excluded from the
study. Patients treated for suprarenal or thoraco-abdominal aneurysms were also excluded.
All stent grafts used were customised based on the Zenith system. Indications for repair, oper-
ative and postoperative mortality and morbidity were evaluated. Differences between groups
were determined using analysis of variance with P < 0.05 considered significant.
Results: One hundred patients (87 males/13 females) with a median age of 73 years (range,
50e91 years) were treated during the study period; this included 16 patients after previous
open surgery or EVAR. Thirty-day mortality was 1%. Intra-operative conversion to open repair
was needed in one patient. Operative visceral vessel perfusion rate was 98.9% (272/275).
Median follow-up was 24 months (range, 1e87 months). Twenty-two patients died during
follow-up, all aneurysm unrelated. No aneurysm ruptured. Estimated survival rates at 1,
2 and 5 years were 90.3  3.1%, 84.4  4.0% and 58.5  8.1%, respectively. Cumulative visceral
branch patency was 93.3  1.9% at 5 years. Visceral artery stent occlusions all occurred within
the first 2 postoperative years. Four renal artery stent fractures were observed, of which three
were associated with occlusion. Twenty-five patients had an increase of serum creatinine ofjvs.2009.12.008.
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530 E.L.G. Verhoeven et al.more than 30%; two of them required dialysis. In general, mean aneurysm sac size decreased
significantly during follow-up (P < 0.05).
Conclusions: Fenestrated stent grafting for short-necked and juxtarenal abdominal aortic
aneurysm appears safe and effective on the longer term. Renal function deterioration,
however, is a major concern.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Since the first report of a juxtarenal abdominal aortic
aneurysm (AAA) endovascularly treated with a fenestrated
stent graft in 1999,1 a number of published series have
demonstrated excellent early and mid-term results of the
technique.2e7 A recently published systematic review
confirms the potential lower perioperative mortality of the
technique in comparison with open repair, but acknowl-
edges the lack of longer-term data.8 Fenestrated stent
grafts are now commercially available and provide an
alternative to open surgery, especially in patients who are
at increased risk for open repair.
In our institution, the fenestrated technique was initially
used for patients refused for open surgery. With increasing
experience, however, surgical candidates were also
considered for fenestrated stent grafting. Patients with
proximal anastomotic aneurysms after open surgery or type
I endoleaks after endovascular aneurysm repair (EVAR)
were also successfully treated with fenestrated stent
grafts.9,10
In this article, we present our 8-years’ experience with
the technique in the first 100 patients treated at our
institution.
Materials and Methods
Subjects
All patients treated with fenestrated and branched stent
grafts at our tertiary referral centre or elsewhere under
the supervision of the first author have been enrolled in an
investigational device protocol database. Patients with
short-necked or juxtarenal AAA, treated between
November 2001 and April 2009, were retrospectively
analysed. A short-necked aneurysm was defined as having
a proximal neck length below the lowest renal artery of
4e12 mm. A juxtarenal aneurysm was defined as having
a neck length of less than 4 mm. Patients with a supra-
renal AAA or a thoraco-abdominal aortic aneurysm treated
with fenestrated and branched techniques were excluded
from this report. Patients who were treated elsewhere
under the direct supervision of the main author were also
excluded. The research protocol was reviewed and
approved by the Institutional Review Board. Informed
consent was obtained for all patients. All patients were
classified using guidelines from the American Society of
Anaesthesiologists (ASA). Main indication for F-EVAR
included a proximal neck too short for standard EVAR,
but otherwise suitable anatomy for EVAR in an AAA of
at least 55 mm in diameter (or an AAA smaller than 55 mm
but in conjunction with iliac aneurysm larger than
35 mm).Preoperative assessment and devices
Aneurysm morphology was assessed by thin-cut (1.5 mm)
spiral computerised tomography angiography (CTA) with
axial and coronal reconstructions. Customised fenestrated
devices based on the Cook Zenith system (William A. Cook
Australia, Ltd., Brisbane, Australia) were designed based on
the multiplanar reconstructions to define the exact relative
position of visceral vessels. A three-part composite system
including a proximal tubular body containing the fenestra-
tions, a distal bifurcated graft and a contralateral limb was
used in most cases. The composite system simplifies the
deployment and repositioning of the first tubular graft to
facilitate catheterisation of the target vessels. In addition,
direct migration forces on the tube graft are lower than on
a bifurcated graft. The term ‘fenestration’ includes small
fenestrations (holes at some distance of the top of the
graft, mostly used for the renal arteries) and scallops
(opening in the top of the fabric, used for the top target
vessel, usually the superior mesenteric artery (SMA)).
Delivery of an ordered fenestrated graft nowadays takes
4e6 weeks.
Procedures
Detailed reports of the fenestrated technique have been
published before.3,5,11 In brief, the technique involves
catheterisation of small fenestration target vessels and
stenting with either uncovered stents (in short-necked
aneurysms) or covered stents (in juxtarenal aneurysms).
Stents are flared inside the main body of the stent graft to
improve fixation. After stenting of each target vessel,
a selective angiography is performed to demonstrate
patency and outflow. Completion angiography at the end of
the procedure is performed to confirm target vessel
perfusion, correct stent-graft placement and absence of
endoleak.
Follow-up
Postoperatively, patients were usually prescribed double
anti-platelet therapy (aspirin lifelong and clopidogrel for
2 months). Prior to discharge, patients were evaluated with
clinical examination and renal function laboratory exami-
nation and abdominal radiography. CTA was performed
1 month after the procedure, at 1 year and yearly there-
after. Abdominal X-rays were analysed specifically to
detect stent fractures, disconnections and components
separation or migration. Pre- and postoperative renal
function was monitored by serum creatinine measure-
ments. Elevation of serum creatinine was considered
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than 30% from preoperative levels. In case of suspicion of
a significant endoleak or branch vessel malperfusion,
angiography was performed for further evaluation.
Data analysis
SPSS (SPSS Inc., Chicago, IL, USA) for Windows version
16.0, was used for statistical analysis. Differences
between groups were determined using analysis of vari-
ance with P < 0.05 considered significant. Variables are
expressed as mean  standard deviation (SD) in case of
normal distribution, and median plus range if data had
a skewed distribution. Endovascular outcomes, including
technical success, mortality and morbidity and late
procedure-related events with regard to target vessel
patency, endoleak, renal function and re-intervention
were analysed. Technical success was defined as an
endovascularly completed procedure with absence of
endoleak type I or III, and patent target vessels.
Results
Patients
A total of 160 patients with short-necked and juxtarenal
aneurysms were treated with fenestrated stent grafts
during the study period. Sixty patients were treated in
other hospitals under the supervision of the first author,
leaving 100 patients (juxtarenal, n Z 53; short-necked,
nZ 47) for analysis. There were 87 men and 13 women with
a mean age of 72.6  7.4 years (range, 50e91 years).
Preoperative co-morbidity and risk factors of the patients
are listed in Table 1. Eight patients had previous open AAA
repair and another eight patients had undergone previous
standard EVAR.
Aneurysms
Median maximal AAA diameter was 60 mm (range, 43e88
mm). Four patients with an AAA smaller than 55 mm hadTable 1 Preoperative patient characteristics.
Patients (%)
Coronary artery disease/CABG/stenting/
MI > 6 months
39
Congestive heart failure/MI < 6 months 19
Arterial hypertension 75
COPD 26
Diabetes mellitus 18
Hypercholesterolemia 76
Serum creatinine > 100 mmol/l 46
Previous stroke/TIA 9
Smoking (active/past) 25/42
Previous abdominal operation 34
ASA III/IV 83/3
CABG, coronary artery bypass graft; MI, myocardial infarction;
COPD, chronic obstructive pulmonary disease; ASA, American
Society of Anaesthesiologists.iliac aneurysms of more than 35 mm in diameter. Mean
proximal neck length was 3.6  3.5 mm, ranging from 0 to
10 mm.
Devices
Three-part composite systems were used in 95 patients. In
the first patient of this series, a bifurcated graft was used;
this was also the case in four additional patients, all after
previous open surgery (n Z 2) or EVAR (n Z 2) with
a working length too short for the composite system. The
total number of fenestrations was 275, including 192 renal
arteries fenestrations, 78 SMA fenestrations and five coeliac
artery fenestrations (Table 2). The most common combi-
nation included two small fenestrations for the renal
arteries and a scallop for the SMA. This type of graft was
used in 70 patients. Stent grafts with two fenestrations only
were used in 20 patients, and stent grafts with one fenes-
tration in five patients. In the remaining five patients, stent
grafts with four fenestrations were used. Four patients had
three fenestrations for the renal arteries and the SMA, and
a scallop for the coeliac artery. The last patient had three
renal artery fenestrations and a scallop for the SMA.
Operative details
Local anaesthesia was used in 13 patients, regional anaes-
thesia in 37 patients and general anaesthesia in 48 patients.
In two patients, conversion from local to general anaes-
thesia was required.
Themedian procedure time was 180 min (range, 110e540
min). Median blood loss was 200 ml (range, 50e3000 ml).
Median fluoroscopy time was 26 min (range, 5e90 min) and
mean volume of iodinated contrast material used was 193 
50 ml.
Intra-operative complications and technical success
Intra-operative complications occurred in 13 patients. An
overview with intra-operative management and outcome is
shown in Table 3. Six endovascular procedures were
unsuccessful or required open surgery to solve intra-
operative complications. One patient required an openTable 2 Distribution of vessels incorporated into the
fenestrated stent graft and type of fenestration.
Target vessel Type of fenestration
Scallop Small
fenestration
Large
fenestration
Total
Right renal
artery
17 80 97
Left renal
artery
10 84 1 95
SMA 74 4 78
Coeliac artery 5 5
Total 106 168 1 275
SMA, superior mesenteric artery.
Table 3 Intra-operative complications, management and outcome.
Intra-operative
complications
N Intra-operative management Technical
success
Late follow-up
Top cap not retrievable 1 Open conversion Unsuccessful Visceral vessels patent
Stenosis RRA þ LRA 1 Bypass RRA þ pull-down device Unsuccessful Visceral vessels patent
Small type I endoleak 2 Ballooning ? Endoleak resolved
Overlap too short 1 Tube graft extension Successful No endoleak
Renal artery events
Failed Catheterisation 2 e Unsuccessful Occlusion
Perforation 1 Renal artery embolisation Unsuccessful Occlusion
Occlusion of stent 1 Retrograde catheterisation Unsuccessful Renal artery patent
Dissection RRA 1 Stenting Successful Renal artery patent
Dislocation of stent 1 Re-stenting Successful Renal artery patent
Iliac events
Limb disconnection 1 Bridging stent graft Successful Limb occlusion at 3 years
Kinking iliac limb 1 Self-expandable stent Successful Patent
532 E.L.G. Verhoeven et al.conversion during repair of a juxtarenal aneurysm after
previous stent grafting with a Talent graft. A bifurcated
fenestrated graft with an inner contralateral limb was
used. Due to twisting of the ipsilateral limb during repo-
sitioning of the stent graft, the top cap could not be
retrieved. Further attempts resulted in crushing of the
already positioned renal stents, which required an imme-
diate conversion. The patient had a prolonged recovery in
hospital of 22 days, including intensive care stay of 8 days,
but ultimately was discharged in good condition. In the
second patient, where only the right renal artery was
targeted, the graft deployed slightly higher than intended,
creating a severe stenosis of the right renal artery with
impossible access for stenting, but also a stenosis of the
left renal artery due to the higher position of the graft. On
postoperative day 1, the patient underwent open reposi-
tioning of the fenestrated stent graft and a bypass from
the right iliac artery to the right renal artery. The repo-
sitioning consisted of opening the aorta and pulling the
endograft downwards carefully. This resulted in a widely
patent left renal artery. Serum creatinine level at 1 year is
123 mmol l1 (preoperative 70 mmol l1) with both renal
arteries patent. In the third patient, completion angiog-
raphy after an uncomplicated procedure demonstrated an
occlusion of the left renal artery. This was judged to be
caused by crushing the stent during flaring and ballooning
of the contralateral renal artery stent. A retroperitoneal
surgical approach was carried out to catheterise the left
renal artery in a retrograde manner. A wire easily passed
through the crushed stent, which was re-opened by
balloon angioplasty, and flared with a larger balloon. After
6 months, the left renal artery is still patent. In a fourth
patient, a renal artery perforation occurred, which needed
embolisation with a plug (Amplatzer, Boston Scientific,
Natick, MA, USA) and resulted in loss of the kidney. Finally,
in two patients a renal artery could not be catheterised,
which resulted in occlusion of the renal artery and loss of
the kidney.
In five patients, intra-operative complications were
successfully managed with endovascular techniques. Addi-
tional stenting of a renal artery was required in two patients,the first to repair a dissection, the second because the initial
stent dislocated. The dislocated stent was parked in the
aneurysm sac. In two further patients, iliac problems were
successfully managed. In the fifth patient, where a fenes-
trated tube only was implanted to seal a type I endoleak, the
distal landing zone became too short due to crimping of the
distal two sealing stents during downward repositioning. This
was solved with additional tube graft extension.
Finally, in two patients a small type I proximal endoleak
persisted even after ballooning. This was accepted.
Computed tomography (CT) at 1 month showed no evidence
of endoleak, and follow-up in both patients was uneventful
regarding proximal endoleak, with aneurysm shrinkage.
Target vessel patency
The total number of stents used to secure the fenestra-
tions was 169, including 93 covered stents and 76 uncov-
ered stents. Small fenestrations were routinely stented
except in a few patients in the beginning of our experi-
ence. Scallops were generally not stented. The overall
operative target vessel perfusion success rate was 98.9%
(272/275). Three renal artery small fenestrations were not
successfully catheterised and/or stented, as previously
mentioned.
Postoperative mortality and morbidity
Surgical mortality was 1% (n Z 1). This patient, with
a preoperative left ventricular ejection fraction of 23%, was
re-admitted on postoperative day 6 and died 2 days later
due to mesenteric ischaemia. Laparotomy at re-admission
showed a pale left colon but no localised ischaemia.
Therefore, it was decided not to perform a resection of the
colon. Intra-operatively, a stent graft with two renal artery
fenestrations and an SMA scallop was inserted without
technical difficulties, with SMA patency confirmed on
completion angiogram. At autopsy the SMA was patent.
Colon ischaemia may have been induced by occlusion of the
internal iliac arteries due to the introduction sheaths. Non-
Fig. 2 KaplaneMeier estimate of the cumulative overall
visceral branch patency.
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and included two retroperitoneal haematomas, which were
treated conservatively, two cardiac events (myocardial
infarction and arrhythmia), two surgical access site infec-
tions that were treated with antibiotics and wound
dressing, two urinary tract infections, two pulmonary
infections and four cases of urinary retention. Median
hospital stay was 4 days (range, 2e64 days), including the
preoperative admission day.
Late follow-up
Median follow-up was 24 months (range, 1e87 months).
Eight patients refused follow-up after a mean of 32 months
because of old age and co-morbidity, but are still alive
without re-intervention or complication. All-cause late
mortality was 22, all aneurysm unrelated (Fig. 1). Esti-
mated survival rates at 1, 2 and 5 years were 90.3  3.1%,
84.4  4.0% and 58.5  8.1%, respectively. Ten target
vessels in nine patients (renal arteries, n Z 9; SMA, nZ 1)
were lost during follow-up. Cumulative visceral branch
patency was 93.3  1.9% at five years (Fig. 2). Post-
operative stent occlusions all occurred during the first 2
postoperative years (Table 4).
Twenty-five patients had an increase of serum creatinine
of more than 30% during follow-up, with two patients
requiring dialysis. One patient developed acute renal
insufficiency due to simultaneous bilateral renal artery
stent occlusion 9 months postoperatively. The second
patient (preoperative serum creatinine of 206 mmol l1) had
progressive renal function deterioration with two patent
renal arteries, and required dialysis at 3 months post-
operatively. Elevation of serum creatinine level of more
than 30% was not related to preoperative renal function
(for instance, 13 out of 54 patients with preoperative
normal renal function, 12 out of 46 patients withFig. 1 KaplaneMeier estimate of the cumulative overall
patient survival for all-cause mortality during follow-up.preoperative impaired renal function, Pearson chi squared
0.817) During follow-up, four stent fractures were diag-
nosed on abdominal X-ray. In three of them, this resulted in
occlusion of the renal artery (Table 4).
Aneurysm sac size decreased significantly from 63 mm to
56 mm (P < 0.001) during follow-up. In five patients,
aneurysm sac diameter increased more than 5 mm, two
with lumbar artery retrograde endoleak, and one with
inferior mesenteric artery (IMA) retrograde endoleak. In the
other two patients, no reason was found for the aneurysm
sac increase. No type I endoleak was diagnosed during
follow-up. Migration less than 5 mm was suspected in three
cases and probably resulted in occlusion of a renal artery
stent in two patients.
Re-interventions
In total, there were 11 re-interventions in nine (9%) patients.
Besides the two already mentioned early re-interventions
(laparotomy at day 6 for suspected mesenteric ischaemia,
laparotomy at day 1 for bypass RRA and pull-down of the
stent graft), a third patient underwent stenting of iliac
stenoses within 30 days. Late re-interventions (nZ 8) were
performed in six patients. In two patients, catheterisation of
severe renal artery stenosis at 2 and 18months, respectively,
proved impossible, finally resulting in occlusion. A third
patient underwent coil embolisation of a persistent IMA at 3
months. A fourth patient underwent a laparotomy at 4
months to clip persistent lumbar arteries, and subsequently
underwent a (failed) renal artery catheterisation at 13
months. The fifth patient also underwent two re-interven-
tions; the first at 5 months for iliac limb occlusion (treat-
ment: cross-over bypass), the second at 20months to correct
a disconnection between tube and bifurcation (treatment:
thoracic stent graft used to bridge the gap). Finally, a sixth
patient underwent a cross-over bypass at 5 months for iliac
limb occlusion.
Table 4 Occlusion of target vessel, with time of event and outcome.
Patients Occluded
vessel
Type of
fenestration
Use of stent Time of
occlusion
postoperatively
(months)
Cause/possible cause Outcome
1 LRA Fenestration No 2.5 Malpositioning ESC < 30%
2 LRA Scallop No 6 Malpositioning ESC < 30%
3 RRA Scallop No 2 Malpositioning ESC > 30%
4 RRA Fenestration No 0 Failed catheterisation ESC < 30%
5 RRA Fenestration Uncovereda 6 mm 15 Fracture ESC > 30%
6 RRA Fenestration Uncovereda 7 mm 3.5 Fracture ESC > 30%
7 SMA Scallop No 2 Malpositioning Asymptomatic
8 LRA Fenestration Coveredb 7 mm 0 RA perforation ESC < 30%
9 LRA Fenestration Coveredb 7 mm 24 Migration ESC > 30%
10 LRA Fenestration Coveredb 7 mm 18 Fracture ESC > 30%
11 RRA Fenestration Coveredc 7 mm 9 Extreme dehydration Dialysis
LRA Fenestration Coveredc 7 mm 9
12 RRA Fenestration No 0 Failed catheterisation ESC > 30%
LRA, left renal artery; RRA, right renal artery; RA, renal artery; ESC, elevation of serum creatinine.
a Genesis.
b Advanta V12.
c Jostent.
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Fenestrated stent grafting for short-necked and juxtarenal
aneurysms is entering its second decade. In the beginning,
the technique was reserved to a few Australian and
European centres, and one American centre. It is becoming
widespread in Europe, and an American prospective
multi-centre trial was recently published.12 Published
results of expert centres have demonstrated excellent
short- and mid-term results.2e7 A recently published
systematic review confirms the reduction of perioperative
mortality in comparison to open treatment.8 Although
caution has to be exerted in view of selectivity within the
study groups and the lack of rigorous classification, the
fenestrated technique has shown to be safe in experienced
hands. Further development of the fenestrated techniques
also opened the way for endovascular treatment of supra-
renal and even thoraco-abdominal aneurysms.13,14
This series represents one of the largest worldwide
single-centre studies with a 7-year follow-up. Results are in
range with published series from other expert centres. One
percent mortality is remarkably low in view of the
percentage of high-risk patients, including 16 patients
having undergone previous aortic surgery, and the high
proportion of juxtarenal aneurysms (53%). Intra-operative
technical success was equally high with only three out of
275 vessels lost due to technical problems. However,
technical complications (13% in this series) can occur and
do underline the need of both endovascular and open
expertise to rescue the situation. Availability of back-up
materials is equally a priority.
The fenestrated technique is clearly more complex than
standard EVAR. Over time, however, the technique has
reached maturity. Software allowing for CTA multiplanar
reconstructions facilitates preoperative measurement, and
standard order forms are available to allow for quick
ordering of the grafts, with a delivery between 4 and 6weeks. Procedure planning is crucial to achieve success.
This is also reflected in the training programme, which
includes the active presence of an expert for the first three
to five cases only, but persisting additional control of graft
planning. Materials have improved, technical refinements
have been added, both of which result in an overall easier
procedure. Guiding sheaths are nowadays routinely used to
facilitate introduction of stents. Separate puncture of valve
leafs of the sheath in the contralateral femoral artery is the
solution to avoid continuous blood loss induced by multiple
wires through the central lumen of a valve. The use of
a composite system facilitates the repositioning of the graft
for easier catheterisation of the target vessels. Experience
has taught us to position the fenestrations at the highest
possible level during the procedure (i.e., to push up the
graft against the guiding sheaths just before final deploy-
ment): this allows for maximal apposition and even for
some minimal migration downwards (w2 mm) until the
hooks and barbs encroach on the aortic wall to prevent
further migration.15 Stent fractures observed in our series
were all related to less than optimal apposition between
fenestration and target vessel ostium. The fact that all
target vessel occlusions occurred in the first 2 years also
seems to indicate an intra-operative technical imperfection
rather than an inherent stent problem. A learning curve has
to be taken into account as half of the occlusions occurred
in non-stented fenestrations or scallops in the early stages
of our experience. Nowadays, stenting of a fenestration is
mandatory. Scallops underwent an important modification
with the introduction of a double ring reinforcement, which
prevents them from narrowing down. Indeed, the non-
reinforced scallop being the weakest link in the oversized
top stent sometimes resulted in folding and narrowing of
the opening (Fig. 3).
Late renal events are a concern and have been reported
before.16 In this series, similarly, 25 patients had a signifi-
cant deterioration of renal function. This is not explained
Fenestrated Stent Grafting of AAA 535by occlusions only. Two patients required dialysis, the first
of which had an acute onset of bilateral renal artery
occlusion during a summer holiday 9 months after the
procedure. This might have been explained by dehydration
during physical activity in the heat. The second patient
with a preoperative impaired renal function, was diagnosed
to have cholesterol emboli and required dialysis at
3 months. Other patients experienced decrease of renal
function without occlusion of renal arteries. This was not
related to preoperative renal function. Repeated exami-
nations with iodated contrast postoperatively may have
played a role in this decrease of renal function. This was
also suggested by Mills et al. in their comparison of open
repair versus standard EVAR, and raises the question
whether we should reduce the number of postoperative
contrast-enhanced CT scans.17
A comparison with open surgery is difficult. A clear
publication bias needs to be acknowledged. Selection bias
is probably less important as many patients were high risk
for open surgery. A recent report of open surgery for short-
necked and juxtarenal aneurysms from the Mayo clinic
seems to demonstrate comparable results to fenestrated
EVAR.18 However, other reports do underline the risk of
open surgery in more complex AAA, especially in the pres-
ence of preoperative impaired renal function.19,20 A rand-
omised trial could answer a number of questions but may be
difficult to achieve in view of lower number of patients
presenting with these more complex aneurysms, and the
fact that only a few centres have acquired enoughFigure 3 Autopsy image of an original non-reinforced SMA
scallop of a fenestrated graft. Please note the narrowing due
to over sizing of the graft versus the aortic wall diameter.experience to conduct such a trial. We may need such
a trial to convince health-care providers to support these
techniques.8 Another important question is who should be
offered the technique as more than 40% of patients died of
another cause within 5 years after the procedure. However,
not a single patient experienced or died from aneurysm
rupture.
Finally, at this moment fenestrated grafts still require
4e6 weeks’ planning and delivery and are therefore not
applicable in cases requiring more urgent treatment.Conclusions
Fenestrated stent grafting for short-necked and juxtarenal
aortic aneurysms demonstrates promising results in the
short and mid-term, and is safe and effective in the
prevention of aneurysm rupture. Renal function deteriora-
tion is a concern in a substantial number of patients.
To allow widespread application of the technique, contin-
uous efforts must be placed in training new centres on
patient selection, device measurement and the develop-
ment of new materials and techniques.Conflicts of Interest
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